创尔生物 (831187.oc)

+ 收藏

财务摘要(报告期)(创尔生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年三季报2023年中报2022年年报2022年三季报2022年中报
每股指标:
 每股收益 - 基本(元) 0.550.390.250.410.250.17
 每股收益 - 稀释(元) 0.550.390.250.410.250.17
 每股收益 - 期末股本摊薄(元) 0.550.390.250.410.250.17
 每股净资产BPS(元) 4.184.034.043.79-3.54
 每股经营活动产生的现金流量净额(元) 0.840.560.400.660.330.25
 每股营业收入(元) 3.602.491.642.852.001.25
关键比率:
 净资产收益率 - 摊薄(%) 13.199.796.2510.92-4.67
 净资产收益率 - 加权(%) 13.709.886.4611.38-4.61
 净资产收益率 - 平均(%) 13.8310.086.4611.35-4.70
 净资产收益率 - 扣除(%) 12.018.845.659.38-3.87
 总资产净利率 - 平均(%) 11.768.485.559.15-3.65
 总资产报酬率ROA(%) 14.019.836.4110.87-4.94
 投入资本回报率ROIC(%) 13.379.716.2010.6713.114.37
 销售毛利率(%) 79.1078.5778.6877.6378.4479.17
 销售净利率(%) 15.3215.8215.4314.5212.3813.14
 资产负债率(%) 15.4417.2113.8014.48-20.07
 资产周转率(倍) 0.770.540.360.630.440.28
 销售商品提供劳务收到的现金/营业收入(%) 104.65104.35102.83106.83103.49104.55
 营业利润同比增长率(%) 29.3633.5728.3320.44--16.03
 营业收入同比增长率(%) 26.4824.4731.040.68--0.92
 利润总额同比增长率(%) 33.1536.9230.9221.19--15.13
 归属母公司股东的净利润同比增长率(%) 33.1958.5052.720.73--33.69
 扣非后归属母公司股东的净利润同比增长率(%) 41.30-57.275.49--36.24
 总资产同比增长率(%) 11.57-5.85-3.62-9.34
 总负债同比增长率(%) 18.92--27.21-40.35-30.09
 净资产同比增长率(%) 10.33-14.148.09-5.70
利润表摘要:
 营业总收入(元) 306,144,618.81211,855,998.98139,559,639.22242,055,714.84170,209,342.38106,653,356.14
 营业总成本(元) 253,287,913.09174,841,521.88115,177,712.98205,131,695.96146,420,516.4490,108,115.13
 营业收入(元) 306,144,618.81211,855,998.98139,559,639.22242,055,714.84170,209,342.38106,653,356.14
 营业利润(元) 53,267,342.0636,959,416.3823,851,853.2941,176,053.3227,671,093.7318,585,773.49
 利润总额(元) 56,208,916.2339,156,946.8725,115,537.2442,214,993.8428,598,010.7419,183,440.11
 净利润(元) 46,897,968.5033,508,417.0721,539,840.2435,146,876.4721,063,886.0614,014,263.49
 归属母公司股东的净利润(元) 46,880,488.8033,481,938.7921,497,184.0535,199,205.4521,124,345.7414,075,973.83
 非经常性损益(元) 4,178,369.313,238,066.012,078,189.824,978,373.68-2,431,458.01
 归属母公司股东的净利润扣除非经常性损益(元) 42,702,119.4930,243,872.7819,418,994.2330,220,831.77-11,644,515.82
资产负债表摘要:
 流动资产(元) 167,865,328.33163,208,195.25159,431,876.11147,501,584.03-161,637,597.11
 固定资产(元) 182,214,533.56173,423,415.71174,527,528.46177,804,770.78-12,697,960.37
 资产总计(元) 420,615,426.45413,464,502.79399,000,201.95376,986,150.60-376,964,594.17
 流动负债(元) 62,631,448.9868,466,750.6451,591,127.0948,255,295.55-66,456,200.04
 非流动负债(元) 2,304,935.742,708,261.853,488,740.916,350,361.34-9,217,265.45
 负债合计(元) 64,936,384.7271,175,012.4955,079,868.0054,605,656.89-75,673,465.49
 股东权益(元) 355,679,041.73342,289,490.30343,920,333.95322,380,493.71-301,291,128.68
 归属母公司股东的权益(元) 355,520,130.32342,121,580.31343,736,246.05322,239,062.00-301,159,078.33
 资本公积(元) 25,168,237.7225,168,237.7225,168,237.7225,168,237.72-25,168,237.72
 盈余公积(元) 42,741,337.1342,741,337.1342,741,337.1342,741,337.13-39,048,010.32
 未分配利润(元) 202,614,177.47189,215,627.46190,830,293.20169,333,109.15-151,946,452.29
现金流量表摘要:
 销售商品提供劳务收到的现金(元) 320,387,005.06221,081,562.47143,510,271.76258,578,769.68176,152,306.16111,501,501.07
 经营活动产生的现金净流量(元) 71,489,523.5947,644,591.9734,396,226.0156,287,316.4328,246,265.9021,497,836.85
 购建固定无形长期资产支付的现金(元) 38,858,517.7329,405,319.7617,183,114.9977,077,318.9951,407,048.2028,868,275.85
 投资支付的现金(元) 104,000,000.0061,000,000.0030,000,000.00159,686,500.00149,986,500.0090,286,500.00
 投资活动产生的现金净流量(元) -33,666,776.85-24,691,934.00-17,533,455.44-49,432,261.29-30,807,707.73-21,700,475.86
 取得借款收到的现金(元) 1,200.001,200.001,200.00---
 筹资活动产生的现金净流量(元) -19,565,971.82-4,451,518.18-2,763,891.49-15,978,040.39-14,506,862.74-13,059,115.53
 现金及现金等价物净增加(元) 18,256,774.9218,501,139.7914,098,879.08-9,122,985.25-17,068,304.57-13,261,754.54
 期末现金及现金等价物余额(元) 74,159,024.5774,403,389.4470,001,128.7355,902,249.6547,956,930.3351,763,480.36
 折旧与摊销(元) 18,331,511.4913,398,052.028,941,835.6413,389,081.51-6,744,794.91
公告日期 2024-04-222023-11-202023-08-302023-04-252023-11-202022-08-29
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院